Programmed cell death (apoptosis) is a complex and tightly controlled process that is vital for the proper development of an organism as well as for maintaining its homeostasis.
ced-3, a key player in programmed cell death in C. elegans, encodes a member of the caspase family of cysteine proteases. One particularly important area that has not been studied is the in vivo targets of the death caspases. In order to reveal downstream targets of CED-3, we have developed a sensitized genetic screen to isolate mutations that partially suppress or delay cell death caused by constitutively activated CED-3 death protease. From this screen, we have identified at least fourteen new genes (
cps-1 to
cps-14; CED-3 protease suppressors). Here we report the genetic, molecular, and biochemical characterization of the
cps-5 gene, which is directly activated by CED-3 to promote cell death.
cps-5 is identified by a single mutation,
sm55, which causes a delay of cell death defect and can block cell death in sensitized genetic backgrounds. We mapped
cps-5 to the left arm of LG III by single nucleotide polymorphism mapping and cloned the gene by transformation rescue.
cps-5 encodes a novel protein that interestingly turns out to be a substrate of CED-3 in vitro. We identified the single CED-3 cleavage site in CPS-5 by N-terminus sequencing of the CPS-5 cleavage products. An Aspartate to Glutamate substitution in CPS-5 that blocks cleavage of CPS-5 by CED-3 in vitro abolishes CPS-5 pro-apoptotic activity in vivo. Moreover, expression of the N-terminal cleavage product of CPS-5 but not the C-terminal cleavage product induces ectopic apoptosis in C. elegans. Therefore, cleavage of CPS-5 by CED-3 is required to activate CPS-5''s proapoptotic activity and CPS-5 is a bona fide CED-3 in vivo target. Interestingly, the N-terminus of CPS-5 contains a putative transmembrane domain that is required for its function. We are now looking for factors that interact with CPS-5 and investigating how CPS-5 promotes cell killing. The identification of CPS-5 as an in vivo CED-3 substrate suggests that our sensitized CED-3 suppressor screen is effective in identifying in vivo CED-3 caspase targets.